275 related articles for article (PubMed ID: 21833767)
1. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
[TBL] [Abstract][Full Text] [Related]
4. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.
Baiocco P; Poce G; Alfonso S; Cocozza M; Porretta GC; Colotti G; Biava M; Moraca F; Botta M; Yardley V; Fiorillo A; Lantella A; Malatesta F; Ilari A
ChemMedChem; 2013 Jul; 8(7):1175-83. PubMed ID: 23733388
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
Venkatesan SK; Shukla AK; Dubey VK
J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
[TBL] [Abstract][Full Text] [Related]
8. Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.
Baiocco P; Franceschini S; Ilari A; Colotti G
Protein Pept Lett; 2009; 16(2):196-200. PubMed ID: 19200044
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of antimony treatment in leishmaniasis.
Baiocco P; Colotti G; Franceschini S; Ilari A
J Med Chem; 2009 Apr; 52(8):2603-12. PubMed ID: 19317451
[TBL] [Abstract][Full Text] [Related]
10. Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides.
Toro MA; Sánchez-Murcia PA; Moreno D; Ruiz-Santaquiteria M; Alzate JF; Negri A; Camarasa MJ; Gago F; Velázquez S; Jiménez-Ruiz A
Chembiochem; 2013 Jul; 14(10):1212-7. PubMed ID: 23744811
[TBL] [Abstract][Full Text] [Related]
11. Modeled structure of trypanothione reductase of Leishmania infantum.
Singh BK; Sarkar N; Jagannadham MV; Dubey VK
BMB Rep; 2008 Jun; 41(6):444-7. PubMed ID: 18593527
[TBL] [Abstract][Full Text] [Related]
12. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
13. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
[TBL] [Abstract][Full Text] [Related]
14. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
[TBL] [Abstract][Full Text] [Related]
15. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of
Madia VN; Ialongo D; Patacchini E; Exertier C; Antonelli L; Colotti G; Messore A; Tudino V; Saccoliti F; Scipione L; Ilari A; Costi R; Di Santo R
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615531
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects.
Angelucci F; Sayed AA; Williams DL; Boumis G; Brunori M; Dimastrogiovanni D; Miele AE; Pauly F; Bellelli A
J Biol Chem; 2009 Oct; 284(42):28977-85. PubMed ID: 19710012
[TBL] [Abstract][Full Text] [Related]
18. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
20. Efficient Dimerization Disruption of
Revuelto A; de Lucio H; García-Soriano JC; Sánchez-Murcia PA; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
J Med Chem; 2021 May; 64(9):6137-6160. PubMed ID: 33945281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
